focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 80.00
Bid: 78.50
Ask: 81.50
Change: 0.00 (0.00%)
Spread: 3.00 (3.822%)
Open: 80.00
High: 80.00
Low: 80.00
Prev. Close: 80.00
BSV Live PriceLast checked at -
British Smaller Companies VCT is an Investment Trust

To maximise Total Return and provide investors with an attractive long-term tax-free dividend yield while maintaining the Company's status as a venture capital trust.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Net Asset Value and Fundraising

27 Aug 2021 15:15

RNS Number : 0692K
British Smaller Companies VCT PLC
27 August 2021
 

British Smaller Companies VCT plc ("the Company")

 

Statement re Net Asset Value and Proposed Fundraising

 

The Company announces that as at 30 June 2021 the unaudited net asset value of its ordinary shares was 88.2 pence per ordinary share, an increase of 12.4 pence per ordinary share (16.4 per cent) over the unaudited net asset value of the ordinary shares as at 31 March 2021. Following payment of the interim dividend of 2.0 pence per ordinary share for the year ending 31 March 2022 on 23 July 2021 the unaudited net asset value is 86.2 pence per ordinary share.

 

Despite a further national lockdown in the first quarter 0f 2021, the strong performance which saw 24.6 per cent growth in net asset value in the previous financial year has continued in the three months to 3o June 2021.

 

Further details of the Company's performance during the period will be included in the Company's unaudited interim management report for the three months ended 30 June 2021 which will be published before the end of September 2021.

 

Subsequent to 30 June 2021 the Company has exchanged contracts to realise a proportion of its investment in Matillion Limited ("Matillion"), as part of a wider fundraising by Matillion. In isolation, the unaudited impact on the Company's net asset value at 30 June 2021 of the proposed fundraising and the partial realisation is estimated to be a further increase of 1.8 pence per ordinary share. The completion of the transaction is subject to a regulatory clearance which is anticipated in the near future.

 

The additional increase of 1.8 pence per ordinary share over the unaudited net asset value of 88.2 pence per ordinary share from this partial realisation is in isolation from other changes in the Company's balance sheet since 30 June 2021.

 

Further to the announcement on 15 June 2021, it is anticipated that the Company's proposed Joint Fundraising with British Smaller Companies VCT2 plc in the 2021/22 tax year will open in the week commencing 20 September 2021, seeking to raise in aggregate £40 million, with an over allotment facility of £20 million. Further details of the Fundraising will be announced at the time of the launch.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK version of Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

For further information, please contact:

 

David Hall YFM Private Equity Limited Tel: 0113 244 1000

 

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFLFISTIIDFIL
Date   Source Headline
23rd Jul 202110:35 amRNSDirector/PDMR Shareholding
23rd Jul 202110:34 amRNSPayment of Dividend and Allotment of Shares
25th Jun 20219:28 amRNSTransaction in Own Shares
15th Jun 20211:30 pmRNSAnnual Financial Report
4th May 20219:14 amRNSDirector Declaration - Non-executive appointment
26th Mar 20218:35 amRNSTransaction in Own Shares
12th Mar 202110:55 amRNSInterim Management Statement
8th Mar 20212:20 pmRNSDirector/PDMR Shareholding
8th Mar 20212:19 pmRNSDirector/PDMR Shareholding
8th Mar 20212:10 pmRNSIssue of Equity and Close of Offer
22nd Feb 20214:15 pmRNSClose of Offer to Further Applications
2nd Feb 202110:00 amRNSOffers for Subscription
2nd Feb 202110:00 amRNSOffers for Subscription
28th Jan 20217:00 amRNSNet Asset Value and Proposed Fundraising
15th Dec 202012:02 pmRNSTransaction in Own Shares
11th Dec 20209:30 amRNSProposed Fundraising
11th Dec 20209:30 amRNSProposed Fundraising
25th Nov 20204:00 pmRNSHalf-year Report
5th Oct 20209:53 amRNSIssue of Equity
28th Sep 20207:18 amRNSTransaction in Own Shares
10th Sep 20201:31 pmRNSResult of AGM
28th Aug 20207:50 amRNSAGM Statement
12th Aug 202010:00 amRNSInterim Management Statement to 30 June 2020
31st Jul 20209:36 amRNSPayment of dividend and issue of equity
29th Jun 202011:51 amRNSTransaction in Own Shares
24th Jun 202011:15 amRNSAnnual Financial Report
26th Mar 20204:30 pmRNSNet Asset Value
20th Mar 20204:00 pmRNSPayment of Dividend
20th Mar 20204:00 pmRNSTransaction in Own Shares
20th Mar 20204:00 pmRNSTemporary suspension of DRIS & Buyback policy
11th Feb 20207:19 amRNS3rd Quarter Results and announcement of dividend
19th Dec 201910:18 amRNSTransaction in Own Shares
21st Nov 20191:00 pmRNSHalf-year Report to 30 September 2019
27th Sep 20199:30 amRNSPurchase of Own Securities and Net Asset Value
11th Sep 20192:46 pmRNSAppointment of non-executive directors
11th Sep 201912:55 pmRNSResult of AGM
15th Aug 20193:14 pmRNSInterim Management Statement
1st Jul 20197:28 amRNSTransaction in Own Shares
26th Jun 20191:43 pmRNSAnnual Financial Report Announcement
12th Jun 20191:34 pmRNSDirector/PDMR Shareholding
12th Jun 201910:25 amRNSPayment of dividend and issue of shares
25th Apr 20191:17 pmRNSDividend Declaration
4th Apr 201912:11 pmRNSDirector/PDMR Shareholding
4th Apr 201912:06 pmRNSDirector/PDMR Shareholding
1st Apr 20193:51 pmRNSIssue of Equity
1st Apr 20193:45 pmRNSIssue of Equity and Close of Offers
27th Mar 20198:14 amRNSTransaction in Own Shares and Net Asset Value
26th Mar 20194:29 pmRNSPublication of Supplementary Prospectus
26th Mar 20194:27 pmRNSPublication of Supplementary Prospectus
22nd Mar 20199:03 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.